Dare Bioscience, Inc. Increase (Decrease) in Deposit Assets
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Deposit Assets of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositOtherAssets · last filed 2026-05-14
- Dare Bioscience, Inc. increase (decrease) in deposit assets for the quarter ending 2026-03-31 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in deposit assets for the quarter ending 2025-06-30 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in deposit assets for the quarter ending 2025-03-31 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in deposit assets for the quarter ending 2024-12-31 was -$459.48K.
- Dare Bioscience, Inc. increase (decrease) in deposit assets for fiscal 2025 was $0.00.
- Dare Bioscience, Inc. increase (decrease) in deposit assets for fiscal 2024 was -$402.41K, a 134.90% decline from fiscal 2023.
- Dare Bioscience, Inc. increase (decrease) in deposit assets for fiscal 2023 was $1.15M.
- Dare Bioscience, Inc. increase (decrease) in deposit assets for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Deposit Assets 3 month | Increase (Decrease) in Deposit Assets 6 month | Increase (Decrease) in Deposit Assets 9 month | Increase (Decrease) in Deposit Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | -$459.48K derived: sum of 3 quarters · filed 2026-05-14 | $280.96K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | -$459.48K derived: sum of 2 quarters · filed 2026-05-14 | $280.96K derived: sum of 3 quarters · filed 2026-05-14 | -$1.37K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$459.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $280.96K derived: sum of 2 quarters · filed 2026-03-26 | -$1.37K derived: sum of 3 quarters · filed 2026-03-26 | -$402.41K 10-K · filed 2026-03-26 |
| 2024-09-30 | $740.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $458.11K derived: sum of 2 quarters · filed 2025-08-14 | $57.06K 10-Q · filed 2024-11-14 | -$542.94K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | -$282.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$683.37K 10-Q · filed 2025-08-14 | -$1.28M derived: sum of 3 quarters · filed 2025-08-14 | $465.67K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$401.05K 10-Q · filed 2024-05-14 | -$1.00M derived: sum of 2 quarters · filed 2025-03-31 | $747.99K derived: sum of 3 quarters · filed 2025-03-31 | $751.93K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.15M derived: sum of 2 quarters · filed 2025-03-31 | $1.15M derived: sum of 3 quarters · filed 2025-03-31 | $1.15M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.75M derived: sum of 2 quarters · filed 2024-11-14 | $1.75M 10-Q · filed 2024-11-14 | $1.75M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $3.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $3.94K 10-Q · filed 2024-08-12 | $3.94K derived: sum of 3 quarters · filed 2024-08-12 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |